img

Global Primary Hyperoxaluria Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Primary Hyperoxaluria Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Primary Hyperoxaluria Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Primary Hyperoxaluria Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Primary Hyperoxaluria Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Primary Hyperoxaluria Drug key manufacturers include Allena Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Dicerna Pharmaceuticals Inc, Intellia Therapeutics Inc and OxThera AB, etc. Allena Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Dicerna Pharmaceuticals Inc are top 3 players and held % sales share in total in 2022.
Primary Hyperoxaluria Drug can be divided into ALLN-230, DCR-PHXC, ALN-GO1 and Others, etc. ALLN-230 is the mainstream product in the market, accounting for % sales share globally in 2022.
Primary Hyperoxaluria Drug is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Primary Hyperoxaluria Drug industry development. In 2022, global % sales of Primary Hyperoxaluria Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Primary Hyperoxaluria Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Allena Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Intellia Therapeutics Inc
OxThera AB
Segment by Type
ALLN-230
DCR-PHXC
ALN-GO1
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Primary Hyperoxaluria Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Primary Hyperoxaluria Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Primary Hyperoxaluria Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Primary Hyperoxaluria Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Primary Hyperoxaluria Drug introduction, etc. Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Primary Hyperoxaluria Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Primary Hyperoxaluria Drug Market Overview
1.1 Primary Hyperoxaluria Drug Product Overview
1.2 Primary Hyperoxaluria Drug Market Segment by Type
1.2.1 ALLN-230
1.2.2 DCR-PHXC
1.2.3 ALN-GO1
1.2.4 Others
1.3 Global Primary Hyperoxaluria Drug Market Size by Type
1.3.1 Global Primary Hyperoxaluria Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Primary Hyperoxaluria Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Primary Hyperoxaluria Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Primary Hyperoxaluria Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Primary Hyperoxaluria Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Primary Hyperoxaluria Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Primary Hyperoxaluria Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Primary Hyperoxaluria Drug Sales Breakdown by Type (2018-2024)
2 Global Primary Hyperoxaluria Drug Market Competition by Company
2.1 Global Top Players by Primary Hyperoxaluria Drug Sales (2018-2024)
2.2 Global Top Players by Primary Hyperoxaluria Drug Revenue (2018-2024)
2.3 Global Top Players by Primary Hyperoxaluria Drug Price (2018-2024)
2.4 Global Top Manufacturers Primary Hyperoxaluria Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Primary Hyperoxaluria Drug Market Competitive Situation and Trends
2.5.1 Primary Hyperoxaluria Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Primary Hyperoxaluria Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Primary Hyperoxaluria Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Primary Hyperoxaluria Drug Market
2.8 Key Manufacturers Primary Hyperoxaluria Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Primary Hyperoxaluria Drug Status and Outlook by Region
3.1 Global Primary Hyperoxaluria Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Primary Hyperoxaluria Drug Historic Market Size by Region
3.2.1 Global Primary Hyperoxaluria Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Primary Hyperoxaluria Drug Sales in Value by Region (2018-2024)
3.2.3 Global Primary Hyperoxaluria Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Primary Hyperoxaluria Drug Forecasted Market Size by Region
3.3.1 Global Primary Hyperoxaluria Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Primary Hyperoxaluria Drug Sales in Value by Region (2024-2034)
3.3.3 Global Primary Hyperoxaluria Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Primary Hyperoxaluria Drug by Application
4.1 Primary Hyperoxaluria Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Primary Hyperoxaluria Drug Market Size by Application
4.2.1 Global Primary Hyperoxaluria Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Primary Hyperoxaluria Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Primary Hyperoxaluria Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Primary Hyperoxaluria Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Primary Hyperoxaluria Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Primary Hyperoxaluria Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Primary Hyperoxaluria Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Primary Hyperoxaluria Drug Sales Breakdown by Application (2018-2024)
5 North America Primary Hyperoxaluria Drug by Country
5.1 North America Primary Hyperoxaluria Drug Historic Market Size by Country
5.1.1 North America Primary Hyperoxaluria Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Primary Hyperoxaluria Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Primary Hyperoxaluria Drug Sales in Value by Country (2018-2024)
5.2 North America Primary Hyperoxaluria Drug Forecasted Market Size by Country
5.2.1 North America Primary Hyperoxaluria Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Primary Hyperoxaluria Drug Sales in Value by Country (2024-2034)
6 Europe Primary Hyperoxaluria Drug by Country
6.1 Europe Primary Hyperoxaluria Drug Historic Market Size by Country
6.1.1 Europe Primary Hyperoxaluria Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Primary Hyperoxaluria Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Primary Hyperoxaluria Drug Sales in Value by Country (2018-2024)
6.2 Europe Primary Hyperoxaluria Drug Forecasted Market Size by Country
6.2.1 Europe Primary Hyperoxaluria Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Primary Hyperoxaluria Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Primary Hyperoxaluria Drug by Region
7.1 Asia-Pacific Primary Hyperoxaluria Drug Historic Market Size by Region
7.1.1 Asia-Pacific Primary Hyperoxaluria Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Primary Hyperoxaluria Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Primary Hyperoxaluria Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Primary Hyperoxaluria Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Primary Hyperoxaluria Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Primary Hyperoxaluria Drug Sales in Value by Region (2024-2034)
8 Latin America Primary Hyperoxaluria Drug by Country
8.1 Latin America Primary Hyperoxaluria Drug Historic Market Size by Country
8.1.1 Latin America Primary Hyperoxaluria Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Primary Hyperoxaluria Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Primary Hyperoxaluria Drug Sales in Value by Country (2018-2024)
8.2 Latin America Primary Hyperoxaluria Drug Forecasted Market Size by Country
8.2.1 Latin America Primary Hyperoxaluria Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Primary Hyperoxaluria Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Primary Hyperoxaluria Drug by Country
9.1 Middle East and Africa Primary Hyperoxaluria Drug Historic Market Size by Country
9.1.1 Middle East and Africa Primary Hyperoxaluria Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Primary Hyperoxaluria Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Primary Hyperoxaluria Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Primary Hyperoxaluria Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Primary Hyperoxaluria Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Primary Hyperoxaluria Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Allena Pharmaceuticals Inc
10.1.1 Allena Pharmaceuticals Inc Company Information
10.1.2 Allena Pharmaceuticals Inc Introduction and Business Overview
10.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Products Offered
10.1.5 Allena Pharmaceuticals Inc Recent Development
10.2 Alnylam Pharmaceuticals Inc
10.2.1 Alnylam Pharmaceuticals Inc Company Information
10.2.2 Alnylam Pharmaceuticals Inc Introduction and Business Overview
10.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Products Offered
10.2.5 Alnylam Pharmaceuticals Inc Recent Development
10.3 Dicerna Pharmaceuticals Inc
10.3.1 Dicerna Pharmaceuticals Inc Company Information
10.3.2 Dicerna Pharmaceuticals Inc Introduction and Business Overview
10.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Products Offered
10.3.5 Dicerna Pharmaceuticals Inc Recent Development
10.4 Intellia Therapeutics Inc
10.4.1 Intellia Therapeutics Inc Company Information
10.4.2 Intellia Therapeutics Inc Introduction and Business Overview
10.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Products Offered
10.4.5 Intellia Therapeutics Inc Recent Development
10.5 OxThera AB
10.5.1 OxThera AB Company Information
10.5.2 OxThera AB Introduction and Business Overview
10.5.3 OxThera AB Primary Hyperoxaluria Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 OxThera AB Primary Hyperoxaluria Drug Products Offered
10.5.5 OxThera AB Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Primary Hyperoxaluria Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Primary Hyperoxaluria Drug Industrial Chain Analysis
11.4 Primary Hyperoxaluria Drug Market Dynamics
11.4.1 Primary Hyperoxaluria Drug Industry Trends
11.4.2 Primary Hyperoxaluria Drug Market Drivers
11.4.3 Primary Hyperoxaluria Drug Market Challenges
11.4.4 Primary Hyperoxaluria Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Primary Hyperoxaluria Drug Distributors
12.3 Primary Hyperoxaluria Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of ALLN-230
Table 2. Major Company of DCR-PHXC
Table 3. Major Company of ALN-GO1
Table 4. Major Company of Others
Table 5. Global Primary Hyperoxaluria Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Primary Hyperoxaluria Drug Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Primary Hyperoxaluria Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Primary Hyperoxaluria Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Primary Hyperoxaluria Drug Market Share in Value by Type (2018-2024)
Table 10. Global Primary Hyperoxaluria Drug Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Primary Hyperoxaluria Drug Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Primary Hyperoxaluria Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Primary Hyperoxaluria Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Primary Hyperoxaluria Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Primary Hyperoxaluria Drug Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Primary Hyperoxaluria Drug Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Primary Hyperoxaluria Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Primary Hyperoxaluria Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Primary Hyperoxaluria Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Primary Hyperoxaluria Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Primary Hyperoxaluria Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Primary Hyperoxaluria Drug Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Primary Hyperoxaluria Drug Sales Share by Company (2018-2024)
Table 28. Global Primary Hyperoxaluria Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Primary Hyperoxaluria Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Primary Hyperoxaluria Drug Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Primary Hyperoxaluria Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Primary Hyperoxaluria Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Primary Hyperoxaluria Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Primary Hyperoxaluria Drug Market
Table 35. Key Manufacturers Primary Hyperoxaluria Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Primary Hyperoxaluria Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Primary Hyperoxaluria Drug Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Primary Hyperoxaluria Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Primary Hyperoxaluria Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Primary Hyperoxaluria Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Primary Hyperoxaluria Drug Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Primary Hyperoxaluria Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Primary Hyperoxaluria Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Primary Hyperoxaluria Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Primary Hyperoxaluria Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Primary Hyperoxaluria Drug Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Primary Hyperoxaluria Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Primary Hyperoxaluria Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Primary Hyperoxaluria Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Primary Hyperoxaluria Drug Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Primary Hyperoxaluria Drug Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Primary Hyperoxaluria Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Primary Hyperoxaluria Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Primary Hyperoxaluria Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Primary Hyperoxaluria Drug Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Primary Hyperoxaluria Drug Sales by Application (2018-2024) (K Pcs)
Table 60. North America Primary Hyperoxaluria Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Primary Hyperoxaluria Drug Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Primary Hyperoxaluria Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Primary Hyperoxaluria Drug Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Primary Hyperoxaluria Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Primary Hyperoxaluria Drug Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Primary Hyperoxaluria Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Primary Hyperoxaluria Drug Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Primary Hyperoxaluria Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Primary Hyperoxaluria Drug Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Primary Hyperoxaluria Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Primary Hyperoxaluria Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Primary Hyperoxaluria Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Primary Hyperoxaluria Drug Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Primary Hyperoxaluria Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Primary Hyperoxaluria Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Primary Hyperoxaluria Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Primary Hyperoxaluria Drug Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Primary Hyperoxaluria Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Primary Hyperoxaluria Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Primary Hyperoxaluria Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Primary Hyperoxaluria Drug Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Primary Hyperoxaluria Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Primary Hyperoxaluria Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Primary Hyperoxaluria Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Primary Hyperoxaluria Drug Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Primary Hyperoxaluria Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Primary Hyperoxaluria Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Primary Hyperoxaluria Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Primary Hyperoxaluria Drug Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Primary Hyperoxaluria Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Primary Hyperoxaluria Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Primary Hyperoxaluria Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Primary Hyperoxaluria Drug Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Primary Hyperoxaluria Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Primary Hyperoxaluria Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Primary Hyperoxaluria Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Primary Hyperoxaluria Drug Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Primary Hyperoxaluria Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Primary Hyperoxaluria Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Primary Hyperoxaluria Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Primary Hyperoxaluria Drug Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Primary Hyperoxaluria Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Primary Hyperoxaluria Drug Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Primary Hyperoxaluria Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Allena Pharmaceuticals Inc Company Information
Table 110. Allena Pharmaceuticals Inc Introduction and Business Overview
Table 111. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 113. Allena Pharmaceuticals Inc Recent Development
Table 114. Alnylam Pharmaceuticals Inc Company Information
Table 115. Alnylam Pharmaceuticals Inc Introduction and Business Overview
Table 116. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 118. Alnylam Pharmaceuticals Inc Recent Development
Table 119. Dicerna Pharmaceuticals Inc Company Information
Table 120. Dicerna Pharmaceuticals Inc Introduction and Business Overview
Table 121. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 123. Dicerna Pharmaceuticals Inc Recent Development
Table 124. Intellia Therapeutics Inc Company Information
Table 125. Intellia Therapeutics Inc Introduction and Business Overview
Table 126. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product
Table 128. Intellia Therapeutics Inc Recent Development
Table 129. OxThera AB Company Information
Table 130. OxThera AB Introduction and Business Overview
Table 131. OxThera AB Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. OxThera AB Primary Hyperoxaluria Drug Product
Table 133. OxThera AB Recent Development
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Primary Hyperoxaluria Drug Market Trends
Table 137. Primary Hyperoxaluria Drug Market Drivers
Table 138. Primary Hyperoxaluria Drug Market Challenges
Table 139. Primary Hyperoxaluria Drug Market Restraints
Table 140. Primary Hyperoxaluria Drug Distributors List
Table 141. Primary Hyperoxaluria Drug Downstream Customers
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Primary Hyperoxaluria Drug Product Picture
Figure 2. Global Primary Hyperoxaluria Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Primary Hyperoxaluria Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Primary Hyperoxaluria Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of ALLN-230
Figure 6. Global ALLN-230 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of DCR-PHXC
Figure 8. Global DCR-PHXC Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of ALN-GO1
Figure 10. Global ALN-GO1 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Primary Hyperoxaluria Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Primary Hyperoxaluria Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Primary Hyperoxaluria Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Primary Hyperoxaluria Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Primary Hyperoxaluria Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Primary Hyperoxaluria Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Primary Hyperoxaluria Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Primary Hyperoxaluria Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Primary Hyperoxaluria Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Primary Hyperoxaluria Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Primary Hyperoxaluria Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Primary Hyperoxaluria Drug Revenue in 2022
Figure 27. Primary Hyperoxaluria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Global Primary Hyperoxaluria Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Primary Hyperoxaluria Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Primary Hyperoxaluria Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Primary Hyperoxaluria Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Primary Hyperoxaluria Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Primary Hyperoxaluria Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Primary Hyperoxaluria Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Primary Hyperoxaluria Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Primary Hyperoxaluria Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Primary Hyperoxaluria Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Primary Hyperoxaluria Drug Manufacturing Cost Structure
Figure 47. Primary Hyperoxaluria Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries